Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead 2vt Regulatory News (BMD)

Share Price Information for Baronsmead 2vt (BMD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 55.50
Bid: 54.00
Ask: 57.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.556%)
Open: 55.50
High: 55.50
Low: 55.50
Prev. Close: 55.50
BMD Live PriceLast checked at -
Baronsmead Second Venture Trust is an Investment Trust

To achieve long-term investment returns for private investors by investing primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

11 Mar 2016 16:49

RNS Number : 9037R
Baronsmead VCT 3 PLC
11 March 2016
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR south africa OR any jurisdiction in which the same could be unlawful. the information contained herein does not constitute an offer of securities for sale in any jurisdiction, including in the united states, CANADA, australia, japan OR south africa.

BARONSMEAD VCT 3 PLC

11 MARCH 2016

ISSUE OF NEW SHARES IN CONNECTION WITH THE RECONSTRUCTION AND WINDING UP OF BARONSMEAD VCT 4 PLC AND OFFER FOR SUBSCRIPTION

Issue of New Shares pursuant to the Scheme

The Board of Baronsmead VCT 3 plc (the "Company") refers to the circular and prospectus published by the Company on 27 January 2016 in connection with, inter alia, the participation of the Company in the proposed scheme for the reconstruction and winding up of Baronsmead VCT 4 plc ("BVCT4"). 

The Board is pleased to announce that, following the passing of the resolutions at the general meeting of BVCT4 earlier today, the Company will acquire £70.68 million of assets of BVCT4 in consideration for the issue of New Shares to BVCT4 Shareholders. The portfolio of assets acquired is identical to the Company's current portfolio, with the exception of one unquoted investment and the investment in Wood Street which are held by the Company, but not BVCT4.

The number of New Shares to be issued to BVCT4 Shareholders under the BVCT4 Scheme will be based on the adjusted Net Asset Value of an Ordinary Share (the "FAV per Ordinary Share") and the adjusted Net Asset Value of a BVCT4 Share (the "FAV per BVCT4 Share"). The FAV per Ordinary Share and the FAV per BVCT4 Share were calculated as at close of business on 29 February 2016. The FAV per Ordinary Share was 103.94 pence and the FAV per BVCT4 Share was 96.58 pence. Accordingly, BVCT4 Shareholders will receive approximately 0.92919 New Shares for every BVCT4 Share.

Applications have been made for the New Shares to be issued pursuant to the Scheme to be admitted to the Official List (with a Premium Listing) and to the London Stock Exchange for the New Shares to be admitted to trading on the Main Market. It is expected that Admission will occur and dealings will commence in the New Shares to be issued pursuant to the Scheme at 8.00 a.m. on 16 March 2016.

Issue of New Shares pursuant to the Offer

The Board is also pleased to announce that the Company has raised gross proceeds of £10 million pursuant to the Offer set out in the prospectus.

New Shares issued under the Offer will be issued at an issue price of 107.2 pence. The issue price has been calculated by dividing the Company's latest published Net Asset Value of 103.94 pence as at 29 February 2016 by 0.97 in accordance with the pricing formula set out under the Offer.

Applications have been made for the New Shares to be issued pursuant to the Offer to be admitted to the Official List (with a Premium Listing) and to the London Stock Exchange for the New Shares to be admitted to trading on the Main Market. It is expected that Admission will occur and dealing will commence in the New Shares to be issued pursuant to the Offer at 8.00 a.m. on 16 March 2016. A further announcement is expected to be made on 15 March 2016 with respect the number of New Shares allotted under the Offer.

Changes to the Board

Following approval of the Proposals, Robert Owen and Malcolm Groat have joined the board of the Company as non-executive directors, with immediate effect. In addition, Gillian Nott OBE and Andrew Karney have retired as Directors of the Company. Save for as disclosed in the Prospectus, there are no other details to be disclosed pursuant to Listing Rule 9.6.13 in relation to this Board appointment. A copy of the Prospectus is available for inspection at the National Storage Mechanism, which is located at http://www.morningstar.co.uk/uk/NSM.

 

Change of Name

Following the Merger, the Company expects to change its name to "Baronsmead Second Venture Trust plc" on 14 March 2016. Trading is expected to commence on 15 March 2016 under the new name. The Company's ticker, ISIN and SEDOL will remain the same.

Definitions

Terms defined in the circular published by the Company dated 26 January 2016 have the same meanings in this announcement unless the context requires otherwise.

Further information

For further information please contact.

Michael Probin - VCT investor relationsLivingbridge VC LLP020 7506 5796

Notes

This announcement is for information purposes only and does not purport to be full or complete and any decision regarding the Proposals should be made only on the basis of the Circular and the Prospectus. 

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor. 

The issue and the distribution of this announcement, the Circular and/or the Prospectus in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to this announcement, the Circular and/or the Prospectus comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEQFLFFQXFZBBV
Date   Source Headline
2nd Aug 202112:42 pmRNSTotal Voting Rights
23rd Jul 20215:27 pmRNSTransaction in Own Shares
21st Jul 20219:30 amRNSNet Asset Value(s)
1st Jul 202110:29 amRNSTotal Voting Rights
9th Jun 20216:23 pmRNSTransaction in Own Shares
4th Jun 20216:00 pmRNSNet Asset Value(s)
27th May 20213:35 pmRNSHalf-year Report
7th May 20214:15 pmRNSNet Asset Value(s)
15th Apr 20215:00 pmRNSNet Asset Value(s)
1st Apr 202110:16 amRNSTotal Voting Rights
30th Mar 20216:01 pmRNSTransaction in Own Shares
18th Mar 20213:22 pmRNSIssue of New Shares
9th Mar 202112:03 pmRNSSale of shares from Treasury
3rd Mar 20215:15 pmRNSNet Asset Value(s)
2nd Mar 202112:41 pmRNSOffer for Subscription - Update
1st Mar 202112:43 pmRNSTotal Voting Rights
26th Feb 202111:26 amRNSIssue of New Shares
16th Feb 20215:14 pmRNSResult of AGM
15th Feb 20219:22 amRNSUpdate on Fundraising
5th Feb 202110:00 amRNSNet Asset Value(s)
1st Feb 202112:22 pmRNSTotal Voting Rights
29th Jan 20211:30 pmRNSIssue of New Shares
27th Jan 20215:30 pmRNSTransaction in Own Shares
27th Jan 202111:27 amRNSPublication of Supplementary Prospectus
21st Jan 20215:45 pmRNSNet Asset Value(s)
6th Jan 202110:37 amRNSUpdate on Fundraising
4th Jan 202112:05 pmRNSTotal Voting Rights
18th Dec 20207:00 amRNSIssue of Equity
17th Dec 20205:45 pmRNSTransaction in Own Shares
14th Dec 202012:27 pmRNSAppointment of Non-Executive Director
4th Dec 20204:15 pmRNSNet Asset Value(s)
3rd Dec 20206:00 pmRNSAnnual Financial Report For Y/E 30/09/20
1st Dec 202010:37 amRNSTotal Voting Rights
27th Nov 20201:05 pmRNSCorrection: Directorate Change
25th Nov 20203:51 pmRNSDirectorate Change
10th Nov 20203:08 pmRNSDirector/PDMR Shareholding
10th Nov 20202:58 pmRNSDirector/PDMR Shareholding
10th Nov 20202:44 pmRNSDirector/PDMR Shareholding
10th Nov 20202:41 pmRNSDirector/PDMR Shareholding
10th Nov 20201:44 pmRNSIssue of New Shares
5th Nov 20201:00 pmRNSNet Asset Value(s)
2nd Nov 202011:15 amRNSTotal Voting Rights
27th Oct 20203:51 pmRNSTransaction in Own Shares
20th Oct 20207:00 amRNSNet Asset Value(s)
14th Oct 202011:01 amRNSManagement Engagement & Remuneration Committee
7th Oct 20205:10 pmRNSOffer update – Extension of Earlybird Rebate
1st Oct 202011:00 amRNSTotal Voting Rights
29th Sep 202011:22 amRNSTransaction in Own Shares
17th Sep 20209:00 amRNSPublication of a Prospectus
11th Sep 20204:44 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.